US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. ... US FDA Launches AI Tool to Reduce Time Taken for Scientific Reviews. Top News. News.

The US Food and Drug Administration (FDA) has cleared cell-based seafood company Wildtype to market products, marking a first for the sector. The agency issued a “no questions” letter ...

US FDA: The U.S. FDA has launched Elsa, a cutting-edge generative AI tool designed to enhance efficiency in scientific reviews and expedite drug approval processes, aimed at reducing evaluation ...

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews.

US FDA approves Moderna’s next-generation COVID-19 vaccine, with caveats The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

Moderna's new COVID-19 vaccine approved by FDA for ages 65+ and 12-64 with underlying risk factors. June 18, 2025 e-Paper. LOGIN Account. ... Connect with us. June 18, 2025 e-Paper.

Once the FDA receives an application for a potential drug approval, ... 800-290-4726 more ways to reach us. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to ...

US FDA launches AI tool to reduce time taken for scientific reviews Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020.

Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibodyDesignation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of ...

India’s offer comes in the backdrop of the US administration’s stated desire to sharply reduce local drug prices, and gains significance considering every second prescription in the US has a ...

FDA Commissioner Dr. Martin A. Makary said the agency is taking aggressive steps to modernize outdated regulations, expand choice and improve efficiency.

FDA commissioner Marty Makary discusses COVID vaccine recommendations. Posted: June 1, ... and now I'd find it hard to go back to a US-based company — I feel spoiled by the perks.